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Background
Accurate quantification of the ischemic myocardium at
risk (MaR) in patients with ST- elevation myocardial
infarction (STEMI) is paramount in studies of therapies
seeking to reduce infarct size expressed as percent of
MaR. Cardiac magnetic resonance (CMR) is an impor-
tant clinical research tool for determination of MaR and
infarct size in the same examination within one week
after STEMI. Recent data suggest that cardioprotective
interventions such as ischemic postconditioning or
remote conditioning reduce infarct size, but may also
reduce the extent and severity of edema detected with
T2-weighted imaging. Such an effect might limit the
value of determining MaR using T2-weighted sequences.
Contrast enhanced steady-state free precession (CE-
SSFP) imaging for quantifying MaR in STEMI has pre-
viously been validated compared to single photon emis-
sion computed tomography following radiotracer
injection prior to reperfusion. The aim of the current
study was to compare extent and severity of signal
intensity changes in MaR determined from CE-SSFP in
patients with STEMI randomized to postconditioning or
standard percutaneous coronary intervention (PCI).
Methods
Patients (n=76, age 37-87 years) eligible for primary PCI
due to STEMI were randomized to standard PCI (con-
trols, n=38) or postconditioning (n=38) consisting of four
cycles of 60 sec reperfusion and 60 sec of re-occlusion
before permanent reperfusion. CMR (1.5T Signa Excite
Twin Speed, General Electric Healthcare, Waukesha,
Wisconsin, USA) was performed 7.8±1.2 days after myo-
cardial infarction using a protocol in which the contrast
agent (0.2 mmol/kg; Omniscan, GE Healthcare) was
administered before acquisition of short-axis CE-SSFP
images. MaR was determined by manual delineation, in
end-diastole and end-systole, as the contrast-enhanced
myocardial volume in relation to left ventricular mass
(Figure 1). A subgroup of patients underwent quantifica-
tion of the signal intensity ratio of the contrast enhanced
MaR region divided by a remote region.
Results
MaR size did not differ between postconditioning and
controls (mean±SD, 31.9±10.5% vs 32.1±12.2%, p=0.94)
(Figure 2). The MaR signal intensity ratio did not differ
between postconditioning (n=20, 1.8±0.5) and controls
(n=20, 1.8±0.4, p=0.88). The interobserver variability
(n=12) of MaR size by CE-SSFP was 1.4±3.1% of left
ventricular mass.
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Conclusions
Postconditioning affects neither the extent nor severity
of signal intensity changes in MaR quantified by CE-
SSFP performed one week after STEMI. This indicates
that CE-SSFP is an accurate and appropriate imaging
method to quantify MaR in patients with STEMI, even
in the setting of treatment with postconditioning.
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Figure 1 Corresponding left ventricular short axis views from a patient with inferior myocardial infarction. Left panel, infarct size images
with late gadolinium enhancement (LGE) and right panel, myocardium at risk determined by contrast enhanced steady-state free precession at
end-systole (CE-SSFP).
Figure 2 Box-plot with whiskers of myocardium at risk (MaR)
expressed as percent of left ventricle (LV) mass. MaR did not differ
between patients in the control (n=38) and postconditioning (n=38)
groups.
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